Our senior management team has been engaged in life science real estate dating back to the 1980s and includes the founders of the industry, Alan Gold (Chairman and Chief Executive Officer) and Gary Kreitzer (Executive Vice President, General Counsel and Director). Together with a small team of visionaries, Alan and Gary identified the opportunity to apply an institutional investment focus to the underserved life science sector of the real estate market.
| 1989 |
Alan Gold forms Goldstone Real Estate Finance and Investments and establishes the business model for institutional ownership of office and laboratory space for the life science industry. |
| 1997 |
Alan Gold and Gary Kreitzer serve as President and Senior Vice President/In-House Counsel, respectively, for Health Science Properties Trust which executes an initial public offering as Alexandria Real Estate Equities. |
| December 1998 |
Alan Gold and Gary Kreitzer leave Alexandria Real Estate Equities and form Bernardo Property Advisors, Inc. to acquire and manage lab space properties for lease to the life science industry. |
| August 2004 |
BioMed Realty Trust, Inc., a real estate investment trust (REIT), is formed out of Bernardo Property Advisors, Inc. and taken public, trading on the New York Stock Exchange under the ticker symbol “BMR”.
Matthew McDevitt joins BioMed as Vice President, Acquisitions.
|
| August – December 2004 |
Subsequent investments in life science properties in San Diego, San Francisco, Seattle, New York, Pennsylvania and Maryland total $424 million, including the acquisitions of our King of Prussia (PA) and Landmark at Eastview (NY) properties. |
| May 2005 |
A portfolio of seven life science lab space properties in Cambridge, Massachusetts and one property in Lebanon, New Hampshire are acquired, with existing tenants including Genzyme Corporation, Vertex Pharmaceuticals and Dartmouth College. |
| December 2005 |
Entry into the South Lake Union area of Seattle life science market through a joint venture to develop the Fairview Research Center. |
| March 2006 |
Kent Griffin joins BioMed as Chief Financial Officer. |
| May 2006 |
Shady Grove Road in Rockville, Maryland, which serves as Human Genome Sciences’ 635,000 square foot corporate headquarters and laboratory and manufacturing facilities, is acquired in a long-term sale-leaseback transaction, along with Human Genome Sciences’ 290,000 square foot large scale manufacturing facility and adjacent undeveloped land which can support up to an estimated 500,000 rentable square feet of lab space and office facilities. |
| July 2006 |
The Pacific Research Center campus in Newark, California is acquired. The property includes ten buildings comprising approximately 1.4 million square feet of office and lab space, as well as undeveloped land. |
| November 2006 |
The Center for Life Science | Boston is acquired, an over 700,000 square foot, state-of-the-art life science building under development at that time. Located in the heart of Boston's Longwood Medical area, CLSB’s lab space and office facilities are currently over 90% leased on a long-term basis, with tenants including Beth Israel Deaconess Medical Center, Children's Hospital Boston, Dana-Farber Cancer Institute, Kowa Company and the Immune Disease Institute. |
| December 2006 |
Regeneron Pharmaceuticals signs a long-term lease to occupy two new buildings in the Landmark at Eastview campus totaling approximately 194,000 square feet of office and lab space to be constructed by BioMed. |
| February 2007 |
Illumina signs new leases at the Towne Centre Drive property in San Diego totaling 195,000 square feet and expiring in 2023, including an expansion into a new building with 84,000 square feet of office and lab space to be constructed by BioMed. |
| April 2007 |
A joint venture is formed with Prudential Real Estate Investors (PREI®) to complete the acquisition of a portfolio of properties, including approximately 600,000 square feet of life science space completed or under construction and land that can support approximately an estimated 266,000 square feet of life science laboratory and office space in Cambridge, Massachusetts.
Ground-breaking is announced on a major expansion at the Landmark at Eastview campus in Tarrytown, New York for a world-class laboratory and office complex to serve as the corporate headquarters and research development facility of Regeneron Pharmaceuticals.
|
| April 2008 |
Revance Therapeutics signs a new lease for more than 90,000 square feet of office and lab space at the Pacific Research Center in Newark, California. |
| October 2008 |
Novo Nordisk A/S signs new lease for approximately 36,900 square feet of office and lab space at 530 Fairview Avenue in Seattle. |
| November 2008 |
Children’s Hospital Boston, a pre-eminent pediatric research institution and teaching affiliate of the Harvard Medical School, signs an amendment to its lease at the Center for Life Science | Boston for an additional 49,000 square feet, bringing its total occupancy in the facility to over 150,000 square feet.
Alan Gold, BioMed's Chairman and Chief Executive Officer, receives the national Ernst & Young LLP Entrepreneur Of The Year® 2008 Award in the Real Estate, Construction and Hospitality category.
|
| December 2008 |
Kent Griffin is promoted to President and Chief Operating Officer of BioMed. |
| January 2009 |
Vertex Pharmaceuticals signs early extensions and renewals on two leases totaling in excess of 292,000 square feet of space through December 31, 2015 in Cambridge, Massachusetts, including its corporate headquarters.
Kowa Company, one of Japan’s largest privately owned companies and its fifth largest trading company, signs a new lease at the Center for Life Science | Boston for approximately 24,400 square feet of laboratory and office space. The Center for Life Science | Boston is approximately 91% leased.
|
| March 2009 |
Center for Life Science | Boston (CLSB) receives Gold LEED® certification. |
| June 2009 |
BioMed closes on a five-year, $350 million financing for the Center for Life Science | Boston (CLSB) and an $18 million financing for its 9865 Towne Centre Drive property. |
| February 2010 |
Matthew McDevitt is promoted to Executive Vice President, Real Estate. |
| March 2010 |
Two life science buildings located at 55 and 65 West Watkins Mill Road in Gaithersburg, Maryland are acquired comprising approximately 82,400 square feet. The property is fully leased to MedImmune, Inc., a wholly-owned subsidiary of AstraZeneca PLC, and GenVec, Inc., a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. |
| April 2010 |
BioMed receives investment grade corporate credit ratings from Standard & Poor's Rating Services and Moody's Investors Service. |
| May 2010 |
Five life science buildings located at 9704-9714 Medical Center Drive in Rockville, Maryland are acquired comprising approximately 218,000 square feet. The property is fully leased to the J. Craig Venter Institute, a world leader in genomic research. |
| June 2010 |
Strategic real estate partnership with Isis Pharmaceuticals, Inc. expands with the groundbreaking on a 176,000 square foot build-to-suit research and development facility in Carlsbad, CA. |
|
Greg N. Lubushkin is promoted to Chief Financial Officer. |